Organon Announces Quarterly Dividend
Get Alerts OGN Hot Sheet
Join SI Premium – FREE
JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the company’s Board of Directors declared a quarterly dividend of $0.02 for each issued and outstanding share of the company's common stock. The dividend is payable on December 10, 2026, to stockholders of record at the close of business on November 9, 2026.
About Organon
Organon (NYSE: OGN) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across Women’s Health and General Medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 markets.
Headquartered in Jersey City, New Jersey, Organon is committed to advancing access, affordability, and innovation in healthcare. Learn more at www.organon.com and follow us on LinkedIn, Instagram, X, YouTube, TikTok and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261030977126/en/
Organon Media Contacts:
Karissa Peer
(614) 314-8094
Organon Investor Contacts:
Jennifer Halchak
(201) 275-2711
Renee McKnight
(551) 204-6129
Source: Organon & Co.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom's Curv 2g Sells Out in New Mexico, Expands Preview to Illinois
- TechMediaBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in NetworkNewsAudio Release on AI Chip Inspection and Automation Equipment
- Restaurant Industry Celebrates Visionary Leaders Opening Doors to Opportunity for All
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share